Adagio Medical Holdings ADGM
NASDAQ ADGM
$0.66 +0.03 (+3.98%)
As of: Aug 21, 2026 · 1:07 PM EDT

Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024)

Adagio Medical Holdings (ADGM) posted EBIT Margin of 3352.27% for Q3 2024, down 27.87% sequentially from 2621.65% in Q2 2024, and up 1879651.0% YoY from N/an in Q4 2023.

Adagio Medical Holdings (ADGM) EBIT Margin (2023 - 2024) Analysis & Trends

Adagio Medical Holdings has reported EBIT Margin for 2 years, with the latest figure at 3352.27% in Q3 2024.

  • Quarterly EBIT Margin rose 1879651.0% year-over-year to 3352.27% in Q3 2024, while the trailing twelve-month figure through Dec 2025 was 16517.42% (changed N/A YoY) and the FY2024 annual result came in at 23226.77%, down 1391277.0% from the prior year.
  • EBIT Margin fell to 3352.27% in Q3 2024 per ADGM's latest filing, from 2621.65% in the prior quarter.
  • Over five years, EBIT Margin peaked at 2621.65% in Q2 2024 and troughed at 33903.85% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 201.82 Bn 196.22 Bn 7.27 Bn 13.44%
2 Stryker 127.00 Bn 123.52 Bn 4.50 Bn 25.18%
3 Medtronic 118.94 Bn 109.72 Bn 6.41 Bn 19.10%
4 Boston Scientific 74.26 Bn 73.72 Bn 3.85 Bn 21.65%
5 Edwards Lifesciences 51.61 Bn 47.36 Bn 1.35 Bn 29.48%
6 Dexcom 35.00 Bn 33.05 Bn 830.00 Mn 24.33%
7 GE HealthCare Technologies 33.71 Bn 31.60 Bn 2.18 Bn 13.96%
8 Koninklijke Philips 26.25 Bn 22.93 Bn 4.55 Bn 10.30%
9 Steris 23.16 Bn 22.68 Bn 684.20 Mn 19.15%
10 Adagio Medical Holdings 14.55 Mn 14.55 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -3,352.27%
Jun 30, 2024 -2,621.65%
Mar 31, 2024 -33,903.85%
Dec 31, 2023 -6,837.18%
Sep 30, 2023 -22,148.78%